Product Development Partnerships (PDPs): Lessons from PDPs established to develop new health technologies for neglected diseases

There has been little historic research and development (R&D) investment in technologies to address developing country health needs. The reasons for this are numerous and include: High capital costs to undertake the R&D and the long time between R&D investment and ‚Äúcommercialisation” of the resulting technology R&D investment not appropriable (in this case, insufficient commercial… Read more

Briefing Note on Advance Purchase Commitments

HSRC REPORT: This paper discusses the value-added of Advance Purchase Commitments, how they could be used alongside other incentives and investment approaches and the potential impact they might have on different types of product, stages of product development and types of firms, especially regarding health technologies in poor countries.It also highlights the different taxonomies used… Read more